Amylyx Pharmaceuticals, Inc.
AMLX
23 insider filings · Latest: Jun 4, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | Feb 2 9:10 PM | Frates James M | Proposed Sale | 3,557 | $14.65 | $52.1K | — | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Sale | 1,974 | $13.83 | $27.3K | 3,379,465(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Sale | 136,193 | $13.59 | $1.9M | 3,378,621(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Sale | 1,995 | $13.89 | $27.7K | 3,379,398(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Sale | 136,193 | $13.58 | $1.8M | 3,378,546(D) | View → |
| Jan 16, 2026 | Jan 16 9:05 PM | JUSTIN KLEE | Proposed Sale | 1,995 | $13.52 | $27.0K | — | View → |
| Jan 16, 2026 | Jan 16 9:03 PM | JOSHUA COHEN | Proposed Sale | 1,974 | $13.52 | $26.7K | — | View → |
| Jan 15, 2026 | Jan 15 9:17 PM | JOSHUA COHEN | Proposed Sale | 136,193 | $14.07 | $1.9M | — | View → |
| Jan 15, 2026 | Jan 15 9:14 PM | JUSTIN KLEE | Proposed Sale | 136,193 | $14.07 | $1.9M | — | View → |
| Jan 6, 2026 | Jan 6 9:05 PM | Frates James M | Proposed Sale | 3,326 | $11.11 | $37.0K | — | View → |
| Jan 6, 2026 | Jan 6 9:05 PM | Klee Justin B. | Proposed Sale | 7,715 | $11.09 | $85.6K | — | View → |
| Jan 6, 2026 | Jan 6 9:04 PM | Cohen Joshua B | Proposed Sale | 7,715 | $11.09 | $85.6K | — | View → |
| Dec 1, 2025 | Dec 1 9:05 PM | Bedrosian Camille L | Proposed Sale | 6,580 | $14.35 | $94.4K | — | View → |
| Aug 12, 2025 | Aug 12 8:25 PM | GINA MAZZARIELLO | Proposed Sale | 30,000 | $7.82 | $234.6K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Jun 8 8:00 PM | Bernhardt G ZeiherDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Karen FirestoneDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Daphne QuimiDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | George M Milne JRDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Jun 4, 2026 | Jun 8 8:00 PM | Paul R. FonteyneDirector | Grant/Award | 24,372 | $14.31 | 24,372(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Joshua B CohenDirector, Co-Chief Executive Officer | Grant/Award | 373,295 | $14.10 | 373,295(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Gina MazzarielloChief Legal Officer | Grant/Award | 111,990 | $14.10 | 111,990(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | James M FratesChief Financial Officer | Grant/Award | 143,985 | $14.10 | 143,985(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Justin B. KleeDirector, Co-Chief Executive Officer | Grant/Award | 373,295 | $14.10 | 373,295(D) | View → |
| Mar 5, 2026 | Mar 9 8:00 PM | Camille L BedrosianChief Medical Officer | Grant/Award | 143,985 | $14.10 | 143,985(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Option Exercise | 2,818 | $7.57 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Joshua B CohenDirector, Co-Chief Executive Officer | Option Exercise | 197,182 | $7.57 | 2,818(D) | View → |
| Jan 16, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Option Exercise | 2,847 | $7.57 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 2:46 AM | Justin B. KleeDirector, Co-Chief Executive Officer | Option Exercise | 197,153 | $7.57 | 2,847(D) | View → |